FRMultiple sclerosis and spasticity
Spasticity, spasms and some pain may persist despite multiple-sclerosis treatment. Specific cannabinoid medicines have been studied as complementary symptomatic treatment.
Trust you can verify on Google
Google5.0/580 public reviewsRead all reviews on Google Rating and review count verified September 19, 2026.Understanding multiple sclerosis and spasticity
Multiple sclerosis is a neurological disease that can cause spasticity, weakness, pain, fatigue and balance problems. Disease-modifying treatment and follow-up belong with a specialist team and should never be stopped without that team.
Medical cannabis and multiple sclerosis and spasticity
The most structured evidence mainly concerns nabiximols, a standardized THC:CBD product, added to treatment for persistent spasticity. Assessment should remain coordinated with neurology and distinguish spasticity, pain and other symptoms.
What the evidence shows
Reviews and meta-analyses report improvement in patient-rated spasticity for some people using nabiximols in addition to usual treatment. Objective clinical measures and individual response may differ.
What it does not establish
Findings for a standardized medicine cannot automatically be generalized to all oils, flower or cannabis concentrations. Cannabinoids do not modify the course of multiple sclerosis.
Points to discuss during the assessment
- The targeted symptom: spasticity, spasms or pain
- Neurology follow-up and disease-modifying treatment
- Balance, falls, cognition and fatigue
- Current antispasticity or sedating medication
Important precautions
- Adverse effects can include drowsiness, dizziness, impaired attention, anxiety or a faster heart rate.
- THC can impair driving and the operation of machinery; never drive while impaired.
- Particular caution is required during pregnancy or breastfeeding, with some heart conditions, or with a personal or family history of psychosis.
- Tell the practitioner about all current medications and supplements so possible interactions can be assessed.
How an assessment works
The request begins remotely throughout Quebec, with no family-doctor referral. The practitioner then determines the required assessment format and may require an in-person visit.
Request online
You leave only your contact details, general topic and best time to reach you — no sensitive medical information.
Clinical assessment
A licensed practitioner reviews your symptoms, history and treatments already tried.
Practitioner's decision
If medical cannabis is appropriate, they issue a document specifying your daily amount.
Registration and follow-up
We guide you toward a licensed seller; the practitioner provides clinical follow-up and adjusts treatment when needed.
Your assessment — Multiple sclerosis and spasticity
Leave only your contact details and the best time to reach you. Requests received during business hours get a same-day callback. This public form asks for no sensitive medical information; the practitioner will assess your situation during the consultation.
Does cannabis slow multiple sclerosis?
Are all products equivalent to nabiximols?
Does Coverleaf guarantee a prescription?
Is it covered by insurance?
Another question?
Related conditions and useful resources
Continue with the most relevant pages on options, safety and next steps. Every case remains individually assessed by a licensed practitioner.
Get assessed
Start your request online without a family-doctor referral. A licensed practitioner then determines the assessment format required for your situation.
General information, not medical advice. Coverleaf does not diagnose and does not guarantee any prescription. For adults of legal age. Emergency: 911.